GSE261563 CX-5461 9 v 8 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE261563_CX-5461_9_v_8_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE261563_CX-5461_9_v_8_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE261563_CX-5461_9_v_8_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE261563_CX-5461_9_v_8_human_up.

Results found

Linked to

 

Label

Description

 

Gene

vesicle associated membrane protein 7

Gene

MSL complex subunit 3B

Gene

cutA divalent cation tolerance like, pseudogene

Gene

small nucleolar RNA host gene 7

Gene

TPTE pseudogene 1

Gene

CTBP1 divergent transcript

Gene

solute carrier family 71 member 3, pseudogene

Gene

long intergenic non-protein coding RNA 467

Gene

small integral membrane protein 48

Gene

zinc finger protein 826, pseudogene

  • Gene

    vesicle associated membrane protein 7


  • Gene

    MSL complex subunit 3B


  • Gene

    cutA divalent cation tolerance like, pseudogene


  • Gene

    small nucleolar RNA host gene 7


  • Gene

    TPTE pseudogene 1


  • Gene

    CTBP1 divergent transcript


  • Gene

    solute carrier family 71 member 3, pseudogene


  • Gene

    long intergenic non-protein coding RNA 467


  • Gene

    small integral membrane protein 48


  • Gene

    zinc finger protein 826, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.